Variant report
Variant | nsv526968 |
---|---|
Chromosome Location | chr3:145187073-145205172 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:145182997..145184814-chr3:145187596..145189465,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs536757380 | chr3:145196801-145196802 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs192374205 | chr3:145196813-145196814 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs576322103 | chr3:145196820-145196821 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs537205351 | chr3:145196821-145196822 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs573294894 | chr3:145196825-145196826 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs149152015 | chr3:145196834-145196835 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs185073076 | chr3:145196921-145196922 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs189059526 | chr3:145196931-145196932 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs143346367 | chr3:145196957-145196958 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs577543942 | chr3:145197004-145197005 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs544724771 | chr3:145197016-145197017 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs192956354 | chr3:145197028-145197029 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs531792575 | chr3:145197111-145197112 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs550008921 | chr3:145197115-145197116 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs562132836 | chr3:145197121-145197122 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs139233618 | chr3:145197143-145197144 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs141907718 | chr3:145197147-145197148 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs545154292 | chr3:145197149-145197150 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs566090653 | chr3:145197169-145197170 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs115176852 | chr3:145197187-145197188 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs537109506 | chr3:145197211-145197212 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs570115804 | chr3:145197213-145197214 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs371127185 | chr3:145197215-145197216 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs537535770 | chr3:145197218-145197219 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs79396041 | chr3:145197230-145197231 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs573736583 | chr3:145197264-145197265 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs557468866 | chr3:145197278-145197279 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs147108543 | chr3:145197283-145197284 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs577582146 | chr3:145197320-145197321 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs184820404 | chr3:145197324-145197325 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs77897803 | chr3:145201207-145201208 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs546103308 | chr3:145201217-145201218 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs564092862 | chr3:145201219-145201220 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs143451208 | chr3:145201236-145201237 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs565064262 | chr3:145201264-145201265 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs73009229 | chr3:145201274-145201275 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs568102713 | chr3:145201317-145201318 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs577153460 | chr3:145201388-145201389 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs528979501 | chr3:145201392-145201393 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs548807683 | chr3:145201402-145201403 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs4681238 | chr3:145201407-145201408 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
42 | rs534246838 | chr3:145201441-145201442 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs558795292 | chr3:145201452-145201453 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs565077445 | chr3:145201466-145201467 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs374606932 | chr3:145201468-145201469 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs544229016 | chr3:145201500-145201501 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs147979409 | chr3:145201519-145201520 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs563779294 | chr3:145201529-145201530 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs556384780 | chr3:145201611-145201612 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs56890976 | chr3:145201613-145201614 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Breast cancer | 22032731 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Colorectal cancer | 18645599 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Blepharophimosis-ptosis-epicanthus inversus syndrome | 22067867 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 21364760 | CNVD |
Mental retardation | 17847001 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Autism | 18923514 | CNVD |
Autism | 22241247 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Autism | 21956041 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Breast cancer | 16608533 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20605837 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:145196800-145197400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
2 | chr3:145201200-145202600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |